Cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia II and impaired renal function using heparin and the platelet GP IIb/IIIa inhibitor tirofiban as anticoagulant [PDF]
, 2000 Andreas Koster +4 more
openalex +1 more source
Drug-Eluting Stents in Primary Angioplasty Long-Term Clinical Outcomes [PDF]
, 2007 INTRODUCTION: The use of drug-eluting stents in the context of mechanical reperfusion following ST-segment elevation myocardial infarction (MI) was initially viewed with concern. The main fear was that the drugs' action in unstable lesions could increase
Bernardes, L +8 more
core
Rescue Use of Tirofiban for Acute Carotid In-Stent Thrombosis
Yonsei Medical Journal, 2008 Carotid artery stenting is widely performed for extracranial carotid artery stenosis. In-stent thrombosis is a rare but potentially devastating complication. We present a case of acute in-stent thrombosis immediately following stent insertion and post-balloon dilatation in a 64-year-old male. Thrombosis was successfully treated by intravenous tirofiban,
Kyung-Yul Lee +3 more
openaire +3 more sources
Acute Coronary Syndromes: Management and Secondary Prevention [PDF]
, 2018 Acute coronary syndromes represent a broad spectrum of ischemic myocardial events including unstable angina, non-ST elevation myocardial infarction and acute ST elevation myocardial infarction, which are associated with high morbidity and mortality. They
Wenaweser, Peter, Windecker, Stephan
core
Comparison of Two Platelet Glycoprotein IIb/IIIa Inhibitors, Tirofiban and Abciximab, for the Prevention of Ischemic Events with Percutaneous Coronary Revascularization [PDF]
, 2001 Eric J. Topol +13 more
openalex +1 more source
Comparison of drug-eluting stents with bare metal stents in patients with ST-segment elevation myocardial infarction [PDF]
, 2017 Aims To evaluate safety and effectiveness of early generation drug-eluting stents (DES) compared with bare-metal stents (BMS) in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI),
da Costa, Bruno R. +11 more
core
Platelet Glycoprotein IIb/IIIa Receptor Inhibition in Non-ST-Elevation Acute Coronary Syndromes [PDF]
, 1999 BACKGROUND: Glycoprotein (GP) IIb/IIIa receptor blockers prevent life-threatening cardiac complications in patients with acute coronary syndromes without ST-segment elevation and protect against thrombotic complications associated ...
Akkerhuis, K.M. (Martijn) +5 more
core
Pharmacotherapy of Acute Coronary Syndromes: Medical Economics with an Emphasis on Clopidogrel [PDF]
, 2018 Summary: Acute coronary syndromes account worldwide for a significant burden of hospital- and societal costs. Pharmacotherapy of acute coronary syndromes consists of a combined antithrombotic therapy.
Bramkamp, Matthias +2 more
core
Anticoagulation during Cardiopulmonary Bypass in Patients with Heparin-induced Thrombocytopenia Type II and Renal Impairment Using Heparin and the Platelet Glycoprotein IIb–IIIa Antagonist Tirofiban [PDF]
, 2001 Andreas Koster +8 more
openalex +1 more source
Glycoprotein Ib activation by thrombin stimulates the energy metabolism in human platelets [PDF]
, 2017 Corona de la Pena, Norma +4 more
core +3 more sources